Beta-Lactam Monotherapy for Patients with Sepsis
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2004 Jul 1;70(1):174.
Clinical Question: Is adding an aminogly-coside antibiotic to a beta-lactam antibiotic more effective than use of a beta-lactam antibiotic alone for treating sepsis in immu-nocompetent patients?
Setting: Inpatient (any location)
Study Design: Meta-analysis (randomized controlled trials)
Synopsis: The investigators of this meta-analysis combined the results of 64 studies enrolling 7,568 patients with sepsis caused by a variety of conditions, including pneumonia, urinary tract infections, and abdominal infections. The randomized or quasirandomized studies compared therapy with a beta-lactam antibiotic alone or in combination with an aminoglyco-side antibiotic. Results of 43 trials that included 5,527 patients showed no difference between monotherapy and combination therapy in all-cause mortality by the end of the study and for up to 30 days of follow-up. Treatment failure occurred less often with monotherapy (number needed to treat = 34; 95 percent confidence interval [CI], 20 to 147). Subgroup analysis found no difference when examining patients with documented Pseudomonas aeruginosa infection, any gram-negative infection, bacteremia, or nonurinary tract infections. Nephrotoxicity occurred significantly more often in patients treated with the aminoglycoside antibiotic (number needed to harm = 15; 95 percent CI, 14 to 17).
Bottom Line: When used alone, a beta-lactam antibiotic is as effective as a combination with an aminoglycoside antibiotic in the treatment of sepsis caused by a variety of infections in immunocompetent patients. (Level of Evidence: 1a)
ALLEN F. SHAUGHNESSY, PHARM.D.
Paul M, et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ. March 20, 2004;328:668-72 [published correction in BMJ April 10, 2004;328:884]. .
Used with permission from Shaughnessy AF. Beta-lactam monotherapy okay for sepsis. Accessed online April 29, 2004, at: http://www.InfoPOEMs.com.
Want to use this article elsewhere? Get Permissions